Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

cindy_elkins_2x

Ex-Genentech exec named as new Juno Therapeutics CIO

January 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, juno therapeutics

Biopharmaceutical firm and cellular immunotherapy specialist Juno Therapeutics has named Cindy Elkins as its new Chief Information Officer, where she …
Appointment
shutterstock_158366573

The PROs and cons of pushing patient centricity

January 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient reported outcomes, pharma

As the pharmaceutical industry places increasing weight on the importance of patient-reported outcomes in securing approvals, Ben Hargreaves examines how …
Feature
spmsdsite

Philippines’ FDA suspends Dengvaxia marketing, Sanofi responds

January 5, 2018 Medical Communications, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

As the Dengvaxia scandal in the Philippines rolls into 2018, it emerges that the country’s Food and Drugs Administration has …
News
davidepsteinheadshot_

Novartis Pharma Ex-CEO takes three roles in two days

January 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Epstein, Flagship Pioneering, biotech, drugs, pharma, pharmaceutical

Former CEO of Novartis Pharmaceuticals, David Epstein, has had a busy start to the year, accepting not one but three …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, J&J, JJ, NICE, Pfizer, Spark Therapeutics, Valeant, top ten

Happy New Year from Pharmafile.com! We hope the first week of 2018 hasn’t been too rough. To the surprise of …
News

Takeda agrees $630m takeover of TiGenix

January 5, 2018 Medical Communications, Sales and Marketing Takeda, TiGenix, biotech, drugs, pharma, pharmaceutical

Takeda already had a strong working relationship with TiGenix, after previously signing a licensing agreement with the Belgium-based pharma company …
News
syneos_health_rgb_tm

INC Research and inVentiv merge to form Syneos Health

January 4, 2018 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing INC Research, Syneos Health, inVentiv Health

With the advent of the new year, INC Research and inVentiv Health have announced they are to merge operations under …
News
j_mendlein

Moderna Therapeutics names Dr John Medlein as new President, Corporate and Product Strategy

January 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Moderna, Moderna Therapeutics, mrna

Messenger RNA (mRNA) therapeutics and vaccines specialist Moderna Therapeutics has announced the appointment of current board member Dr John Medlein …
Appointment
reovirus_-_credit_nih

Common virus able to target brain cancer

January 4, 2018 Medical Communications, Research and Development biotech, brain cancer, drugs, pharma, pharmaceutical

Research emerging from the University of Leeds and The Institute of Cancer research has revealed that a virus, known as …
News

Winter crisis hits, NHS hospitals cancel non-emergency operations

January 3, 2018 Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical

There was ample warning that the NHS looked set to face another difficult winter season, the predictions now look to …
News
4420456374_64a3d7e6aa

Pharmafile.com’s top ten stories of 2017

December 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Actelion, Amgen, AstraZeneca, Cyber attack, EMA, European Commission, Humira, J&J, JJ, Johnson & Johnson, MSD, Sanofi, Shire, Teva, biosimilar, brexit

After a packed year that has flown by, we’ve reached the final top ten of 2017. Below you can find …
News
2018

Seven pharma trends for 2018

December 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2018, M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

Pharmafile.com looks ahead to signpost what we expect will be the key industry trends through the course of 2018.The value of …
Feature
fda2outsideweb

La Jolla Pharmaceutical scores FDA approval for blood pressure treatment

December 22, 2017 Medical Communications, Sales and Marketing FDA, La Jolla pharmaceutical, blood pressure, pharma

The FDA has announced that it has approved La Jolla Pharmaceutical’s Giapreza (angiotensin II) injection for intravenous infusion to increase …
News

Novartis hit by court loss, could spur numerous cases across industry

December 22, 2017 Medical Communications, Sales and Marketing Novartis, biotech, drugs, pharma, pharmaceutical

In a landmark ruling, a Californian court has found that a brand name manufacturer of a drug could be held …
News

Roche boosts oncology portfolio with $1.7bn acquisition

December 22, 2017 Medical Communications, Sales and Marketing Roche, biotech, drugs, ignyta, pharma, pharmaceutical

Roche has announced that it will buy Ignyta, a San Diego-based biotech that has a pipeline of oncology drugs, for …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026